Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CV Sciences (CVSI) EBT (2016 - 2025)

Historic EBT for CV Sciences (CVSI) over the last 14 years, with Q3 2025 value amounting to -$382000.0.

  • CV Sciences' EBT rose 1622.81% to -$382000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.5 million, marking a year-over-year increase of 4111.82%. This contributed to the annual value of -$2.4 million for FY2024, which is 17713.55% down from last year.
  • Latest data reveals that CV Sciences reported EBT of -$382000.0 as of Q3 2025, which was up 1622.81% from -$261000.0 recorded in Q2 2025.
  • CV Sciences' 5-year EBT high stood at $5.7 million for Q1 2023, and its period low was -$9.0 million during Q4 2021.
  • Moreover, its 5-year median value for EBT was -$740000.0 (2024), whereas its average is -$1.2 million.
  • Its EBT has fluctuated over the past 5 years, first plummeted by 247750.0% in 2022, then skyrocketed by 47663.37% in 2023.
  • Quarter analysis of 5 years shows CV Sciences' EBT stood at -$9.0 million in 2021, then skyrocketed by 73.62% to -$2.4 million in 2022, then surged by 63.59% to -$860000.0 in 2023, then increased by 13.95% to -$740000.0 in 2024, then skyrocketed by 48.38% to -$382000.0 in 2025.
  • Its last three reported values are -$382000.0 in Q3 2025, -$261000.0 for Q2 2025, and -$102000.0 during Q1 2025.